Corrigendum: Intracellular Delivery: Exploiting Viral Membrane Topic Peptide.

IF 2.1 4区医学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY

Current drug metabolism Pub Date : 2023-01-01 DOI:10.2174/138920022406230915142021

Stefania Galdiero, Mariateresa Vitiello, Annarita Falanga, Marco Cantisani, Novella Incoronato, Massimiliano Galdiero

引用次数: 0

Abstract

The authors declare that after the publication of the article, it was noticed that two citations were inadvertently omitted. The references have now been included as [74b] and [74c]: [74] (b) Vitiello, M.; Galdiero, M.; Galdiero, M. Inhibition of Viral-Induced Membrane Fusion by Peptides. Protein Pep. Lett., 2009, 16(7), 786-793. (c) Galdiero, S.; Falanga, A.; Vitiello, M.; D'Isanto, M.; Cantisani, M.; Kampanaraki, A.; Benedetti, E.; Browne, H.; Galdiero, M. Peptides containing membrane-interacting motifs inhibit herpes simplex virus type 1 infectivity. Peptides, 2008, 29(9), 1461- 1471. The authors would like to include this reference in the online version of the article to ensure completeness.

查看原文本刊更多论文

更正：细胞内递送：利用病毒膜主题肽。

作者声明，在文章发表后，注意到有两处引文被无意中省略了。参考文献现在被包括为[74b]和[74c]：[74]（b）Vitiello，M。；加尔迪罗，M。；Galdiero，M.肽对病毒诱导的膜融合的抑制作用。蛋白质肽。Lett。，2009，16（7），786-793。（c） Galdiero，S。；Falanga，A。；Vitiello，M。；D‘Isanto，M。；Cantisani，M。；Kampanaraki，A。；Benedetti，E。；Browne，H。；Galdiero，M.含有膜相互作用基序的肽抑制单纯疱疹病毒1型的传染性。肽，2008，29（9），1461-1471。作者希望将此参考资料包含在文章的在线版本中，以确保完整性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current drug metabolism 医学-生化与分子生物学

CiteScore

4.30

自引率

4.30%

发文量

审稿时长

4-8 weeks

期刊介绍： Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism, pharmacokinetics, and drug disposition. The journal serves as an international forum for the publication of full-length/mini review, research articles and guest edited issues in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the most important developments. The journal covers the following general topic areas: pharmaceutics, pharmacokinetics, toxicology, and most importantly drug metabolism. More specifically, in vitro and in vivo drug metabolism of phase I and phase II enzymes or metabolic pathways; drug-drug interactions and enzyme kinetics; pharmacokinetics, pharmacokinetic-pharmacodynamic modeling, and toxicokinetics; interspecies differences in metabolism or pharmacokinetics, species scaling and extrapolations; drug transporters; target organ toxicity and interindividual variability in drug exposure-response; extrahepatic metabolism; bioactivation, reactive metabolites, and developments for the identification of drug metabolites. Preclinical and clinical reviews describing the drug metabolism and pharmacokinetics of marketed drugs or drug classes.